First Time Loading...

Pharmanutra SpA
MIL:PHN

Watchlist Manager
Pharmanutra SpA Logo
Pharmanutra SpA
MIL:PHN
Watchlist
Price: 47.5 EUR -1.25%
Updated: Jun 10, 2024

Cash Flow Statement

Cash Flow Statement
Pharmanutra SpA

Rotate your device to view
Cash Flow Statement
Currency: EUR
Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Operating Cash Flow
Net Income
9
9
8
14
14
17
11
15
14
15
15
16
15
17
14
12
13
10
Depreciation & Amortization
1
1
1
2
2
3
2
2
1
1
1
1
1
1
2
2
3
4
Other Non-Cash Items
1
1
1
(1)
(1)
(1)
1
1
1
1
1
1
2
2
2
1
(3)
(2)
Change in Working Capital
(3)
(2)
2
(4)
(4)
(4)
1
(1)
4
2
1
(2)
(4)
(10)
(9)
(3)
(1)
1
Cash from Operating Activities
6
N/A
9
+35%
12
+38%
11
-10%
12
+9%
14
+23%
15
+2%
17
+15%
20
+20%
20
-4%
19
-5%
16
-13%
14
-10%
11
-27%
9
-16%
12
+36%
12
-1%
12
-1%
Investing Cash Flow
Capital Expenditures
(1)
(2)
(5)
(4)
(2)
(2)
(2)
(3)
(5)
(6)
(9)
(10)
(23)
(26)
(27)
(28)
(13)
(10)
Other Items
(0)
(0)
(0)
1
1
0
(0)
(0)
(1)
(1)
(1)
(11)
(1)
(1)
(1)
9
(1)
(0)
Cash from Investing Activities
(1)
N/A
(2)
-84%
(5)
-126%
(3)
+43%
(1)
+80%
(1)
-92%
(2)
-116%
(3)
-27%
(6)
-76%
(6)
-15%
(10)
-54%
(21)
-111%
(24)
-14%
(26)
-11%
(28)
-7%
(20)
+31%
(15)
+25%
(11)
+28%
Financing Cash Flow
Net Issuance of Common Stock
(0)
(0)
0
(0)
(0)
0
0
0
0
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(0)
Net Issuance of Debt
(1)
0
(0)
0
(5)
(5)
(5)
0
5
4
11
11
11
12
14
8
10
9
Cash Paid for Dividends
(3)
(5)
(5)
(4)
(4)
0
(6)
(6)
(6)
0
(7)
(7)
(7)
0
(8)
(8)
(8)
0
Other
(1)
(5)
(4)
(4)
1
1
3
3
(0)
(0)
(1)
(0)
(0)
(1)
(0)
(1)
(1)
(1)
Cash from Financing Activities
(5)
N/A
(10)
-85%
(9)
+3%
(8)
+13%
(8)
-6%
(8)
+2%
(8)
+4%
(3)
+61%
(2)
+39%
(4)
-130%
1
N/A
2
+179%
2
+4%
3
+35%
4
+54%
(3)
N/A
(1)
+82%
(0)
+63%
Change in Cash
Net Change in Cash
0
N/A
(3)
N/A
(3)
+20%
(0)
+93%
3
N/A
5
+85%
4
-14%
11
+148%
13
+21%
9
-33%
9
+8%
(3)
N/A
(7)
-167%
(13)
-80%
(15)
-16%
(10)
+33%
(3)
+70%
1
N/A
Free Cash Flow
Free Cash Flow
6
N/A
7
+19%
7
+6%
7
-3%
10
+46%
13
+27%
13
-2%
14
+13%
15
+8%
14
-11%
10
-30%
6
-36%
(9)
N/A
(15)
-75%
(19)
-21%
(16)
+13%
(1)
+93%
2
N/A

See Also

Discover More